Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.740 | Biomarker | disease | BEFREE | However, M-CBT treatment did not show significant superiority over standard CBT in the present sample. | 30346186 | 2018 | ||||
|
0.740 | Biomarker | disease | BEFREE | Some evidence suggests equivalence between tCBT and diagnosis-specific CBT (dxCBT), however more investigations are necessary to clarify any difference in efficacy. | 27466074 | 2017 | ||||
|
0.740 | Biomarker | disease | BEFREE | Participants were 125 youth, aged 8-17 years, with a primary diagnosis of SAD, who were randomly assigned to generic CBT (CBT-GEN), social anxiety specific CBT (CBT-SAD) or a wait list control (WLC). | 27988427 | 2017 | ||||
|
0.740 | GeneticVariation | disease | UNIPROT | Substitution of isoleucine for threonine at position 190 of S-opsin causes S-cone-function abnormalities. | 23022137 | 2012 | ||||
|
0.740 | GeneticVariation | disease | UNIPROT | Human tritanopia associated with two amino acid substitutions in the blue-sensitive opsin. | 1531728 | 1992 | ||||
|
0.740 | GermlineCausalMutation | disease | ORPHANET | Human tritanopia associated with a third amino acid substitution in the blue-sensitive visual pigment. | 1386496 | 1992 | ||||
|
0.740 | GeneticVariation | disease | UNIPROT | Human tritanopia associated with a third amino acid substitution in the blue-sensitive visual pigment. | 1386496 | 1992 | ||||
|
0.740 | GermlineCausalMutation | disease | ORPHANET | Human tritanopia associated with two amino acid substitutions in the blue-sensitive opsin. | 1531728 | 1992 | ||||
|
0.740 | GeneticVariation | disease | BEFREE | Human tritanopia associated with two amino acid substitutions in the blue-sensitive opsin. | 1531728 | 1992 | ||||
|
0.740 | Biomarker | disease | CTD_human | |||||||
|
0.740 | Biomarker | disease | HPO | |||||||
|
0.740 | CausalMutation | disease | CLINVAR |